Keyphrases
Silica Nanoparticles (SiNPs)
100%
Receptor-binding Domain
100%
Immunogenicity
100%
SARS-CoV-2 Vaccine
100%
Spike Protein
22%
Antigenicity
22%
Subunit Vaccine
22%
Nanoparticles
11%
Spatial Orientation
11%
Immune Response
11%
Domain-independent
11%
Antigen Presentation
11%
COVID-19
11%
Lymph Node
11%
COVID-19 Pandemic
11%
Nanoparticle Surface
11%
Low Immunogenicity
11%
Particle Distribution
11%
Colloidal Stability
11%
Immune System
11%
Safety Profile
11%
Cellular Immune Response
11%
Neutralization Activity
11%
Virus Neutralization
11%
Viral Vector Vaccine
11%
Antigen-presenting Cells
11%
CD4+ T
11%
Cell Response
11%
MRNA Vaccine
11%
Humoral Immune Response
11%
SARS-CoV-2 Receptor Binding Domain
11%
Adjuvanted
11%
Affinity Maturation
11%
Humoral Response
11%
Cell-mediated Immune Response
11%
Immunogen
11%
Soluble Protein
11%
In Vitro Characterization
11%
Good Safety
11%
T Helper Response
11%
Efficient Transport
11%
Nanoparticle Formulation
11%
Vaccine Platform
11%
Vaccine Protein
11%
Nanoparticle Conjugate
11%
Mouse Immunization
11%
Heterologous Virus
11%
Immunology and Microbiology
Vaccine Efficacy
100%
Immunogenicity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Receptor Binding
100%
Mouse
100%
Adoptive Immunity
20%
Humoral Immunity
20%
Antigenicity
20%
Spike
20%
Subunit Vaccine
20%
Antigen
10%
Viral Vector
10%
COVID-19
10%
Antigen-Presenting Cell
10%
T-Helper Cell
10%
Affinity Maturation
10%
Immune System
10%
Immune Response
10%
Surface Property
10%
Conjugate
10%
Virus Neutralization
10%
Spatial Orientation
10%
Antigen Presentation
10%
Lymph Node
10%